Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIV. uri icon

authors

  • Kousari, Arianna E
  • Wilson, Melissa P
  • Hawkins, Kellie L
  • Bandali, Mohamed Mehdi
  • Henao-Martínez, Andrés F
  • Gardner, Edward M
  • Kristine Erlandson, MD

publication date

  • June 3, 2024